ARIAD Pharmaceuticals, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$5.1M
Doctors Paid
761
Transactions
1,224
2017 Total
$5.1M
Payment Breakdown by Category
Research$2.9M (56.5%)
Consulting$193,585 (3.8%)
Travel$34,348 (0.7%)
Food & Beverage$19,287 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.9M | 146 | 56.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.8M | 7 | 35.8% |
| Consulting Fee | $193,585 | 55 | 3.8% |
| Grant | $107,500 | 2 | 2.1% |
| Space rental or facility fees (teaching hospital only) | $39,575 | 14 | 0.8% |
| Travel and Lodging | $34,348 | 74 | 0.7% |
| Food and Beverage | $19,287 | 926 | 0.4% |
Payments by Type
Research
$2.9M
146 transactions
General
$2.2M
1,078 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| OPTIC | $1.3M | 0 | 36 |
| ALTA | $536,228 | 0 | 26 |
| ALTA 1L | $392,640 | 0 | 39 |
| AP26113 Phase I II | $222,627 | 0 | 12 |
| AP32788 Phase I II | $104,242 | 0 | 7 |
| IST - 022 | $84,096 | 0 | 1 |
| Brigatinib EAP | $67,701 | 0 | 11 |
| IST - Hyper-CVAD and Ponatinib in Ph-Positive andor BCR-ABL Positive Acute Lymphoblastic Leukemia ALL | $52,624 | 0 | 1 |
| Pre-Clinical Cardiovascular effects of TKI's | $48,533 | 0 | 1 |
| PACE | $21,645 | 0 | 2 |
| AP24534 Pre-Clinical Mayo - Biliary Tract Cancers | $16,558 | 0 | 4 |
| Phase I Ponatinib | $9,772 | 0 | 5 |
| GIST | $250.00 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2017 |
|---|---|---|---|---|
| Dr. Sarah Schlesinger, M.d, M.D | Immunopathology | New York, NY | $1.8M | $0 |
| Dr. Kevin Croce, Md, Phd, MD, PHD | Cardiovascular Disease | Chestnut Hill, MA | $27,075 | $0 |
| David Camidge, Md, MD | Medical Oncology | Aurora, CO | $18,200 | $0 |
| Robert Doebele, Md, MD | Medical Oncology | Aurora, CO | $15,095 | $0 |
| Sai-Hong I Ou, Md, MD | Hematology & Oncology | Orange, CA | $14,412 | $0 |
| Corey Langer, Md, MD | Internal Medicine | Philadelphia, PA | $11,765 | $0 |
| Dr. Lyudmila Bazhenova, M.d, M.D | Hematology & Oncology | San Diego, CA | $7,639 | $0 |
| Taral Patel, Md, MD | Medical Oncology | Columbus, OH | $7,547 | $0 |
| Dr. James Mccloskey, M.d, M.D | Hematology | Hackensack, NJ | $6,481 | $0 |
| Elias Jabbour, M.d, M.D | Hematology & Oncology | Houston, TX | $6,292 | $0 |
| Jyoti Patel, Md, MD | Medical Oncology | Chicago, IL | $5,972 | $0 |
| Dr. Benjamin Creelan, Md, Ms, MD, MS | Internal Medicine | Tampa, FL | $5,912 | $0 |
| Howard West, Md, MD | Medical Oncology | Duarte, CA | $5,554 | $0 |
| Alberto Chiappori, Md, MD | Internal Medicine | Tampa, FL | $5,346 | $0 |
| Mohammad Jahanzeb, Md, MD | Hematology & Oncology | Boca Raton, FL | $5,014 | $0 |
| Viola Zhu, Md Phd, MD PHD | Hematology & Oncology | Worcester, MA | $4,922 | $0 |
| Yuanbin Chen, Md, MD | Medical Oncology | Orlando, FL | $4,847 | $0 |
| David Carbone, Md, Phd, MD, PHD | Hematology & Oncology | Columbus, OH | $4,814 | $0 |
| Dr. Christine Lovly, Md, Phd, MD, PHD | Hematology & Oncology | Duarte, CA | $4,655 | $0 |
| Dr. George Simon, Md, MD | Hematology | Celebration, FL | $4,485 | $0 |
| Shirish Gadgeel, Md, MD | Internal Medicine | Detroit, MI | $4,444 | $0 |
| Dr. Martin Dietrich, M.d., Ph.d, M.D., PH.D | Student in an Organized Health Care Education/Training Program | Rockledge, FL | $4,334 | $0 |
| Saad Munib Ahmed Khan, Md, MD | Hematology | Stanford, CA | $4,177 | $0 |
| Ryan Gentzler, M.d, M.D | Internal Medicine | Charlottesville, VA | $3,924 | $0 |
| Dr. Benjamin Levy, Md, MD | Hematology & Oncology | Baltimore, MD | $3,909 | $0 |
Ad
Top Products
- Iclusig $3.6M
- brigatinib $1.5M
Associated Products (2)
- Iclusig $3.6M
- brigatinib $1.5M
Payment Categories
- Food & Beverage $19,287
- Consulting $193,585
- Travel & Lodging $34,348
- Research $2.9M
About ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. has made $5.1M in payments to 761 healthcare providers, recorded across 1,224 transactions in the CMS Open Payments database. In 2017, the company paid $5.1M. The top product by payment volume is Iclusig ($3.6M).
Payments were distributed across 33 medical specialties. The top specialty by payment amount is Immunopathology ($1.8M to 1 doctors).
Payment categories include: Food & Beverage ($19,287), Consulting ($193,585), Research ($2.9M), Travel & Lodging ($34,348).
ARIAD Pharmaceuticals, Inc. is associated with 2 products in the CMS Open Payments database.